ALLIANCEBERNSTEIN L.P. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 97 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$270,000
-16.1%
217,900
+108.1%
0.00%
Q1 2017$322,000
-57.9%
104,700
-44.1%
0.00%
-100.0%
Q4 2016$765,000
-35.7%
187,4000.0%0.00%0.0%
Q3 2016$1,190,000
+17.8%
187,4000.0%0.00%0.0%
Q2 2016$1,010,000
-28.3%
187,400
+11.3%
0.00%0.0%
Q1 2016$1,409,000
+5.9%
168,3000.0%0.00%0.0%
Q4 2015$1,330,000
-8.8%
168,300
-1.8%
0.00%0.0%
Q3 2015$1,458,000
-31.3%
171,300
-0.2%
0.00%
-50.0%
Q2 2015$2,122,000
+10.9%
171,600
+6.5%
0.00%0.0%
Q1 2015$1,914,000
+5.2%
161,1000.0%0.00%0.0%
Q4 2014$1,820,000
+28.7%
161,1000.0%0.00%
+100.0%
Q3 2014$1,414,000
+20.4%
161,1000.0%0.00%0.0%
Q2 2014$1,174,000
+47.7%
161,100
+2.1%
0.00%0.0%
Q1 2014$795,000
+37.8%
157,836
+46.1%
0.00%0.0%
Q4 2013$577,000
-6.2%
108,036
-33.2%
0.00%0.0%
Q3 2013$615,000
-40.9%
161,736
+4.6%
0.00%0.0%
Q2 2013$1,041,000154,6530.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2013
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders